Beam Therapeutics (BEAM) shares rose about 8% in recent trading Wednesday. Leerink Partners upgraded the company's stock to outperform from market perform and adjusted price target upwards to $39 from $27.
Trading volume stood at 1.25 million shares, against a daily average of 845,000.
Price: 25.81, Change: +1.88, Percent Change: +7.86